Carbohydrate-deficient transferrin, a sensitive marker of chronic alcohol abuse, is highly influenced by body iron.

Carbohydrate-deficient transferrin (CDT), a microheterogeneous form of serum transferrin (Tf), has been proposed as the most reliable marker of chronic alcohol consumption, although unexplained false-positive and -negative results have been reported. We investigated whether body iron influenced CDT serum levels by studying alcohol abusers with or without iron overload and nonabusers with iron deficiency or iron overload caused by genetic hemochromatosis (GH). In alcohol abusers, CDT was significantly lower in the presence of iron overload than in the absence (24.6 +/- 16.5 U/L vs. 33.3 +/- 11.7 U/L; P <.01), with false-negative results almost exclusively in patients with iron overload. Similarly, in nonabusers with GH, CDT was lower than in normal controls (9.6 +/- 2. 2 U/L vs. 15.7 +/- 3.3 U/L; P <.0001), whereas, patients with iron deficiency anemia had significantly higher levels than controls (28. 1 +/- 5.8 U/L vs. 15.7 +/- 3.3 U/L; P <.0001). In nonabusers, iron supplementation therapy significantly decreased CDT levels in patients with iron deficiency anemia (33.7 +/- 6.6 U/L vs. 21.7 +/- 5.2 U/L; P =.0007), while iron-depletion treatment significantly increased CDT levels in patients with GH (9.7 +/- 2.0 U/L vs. 14.7 +/- 4.0 U/L; P =.001). Alcohol abusers had a significant relationship between liver iron concentration (LIC) and the reciprocal of CDT (r =.65; P <.0001), while in nonabusers, there was a significant correlation between Tf and CDT (r =.72; P <.0001). In conclusion, CDT serum levels are markedly affected by the patient's iron status, with iron overload reducing its sensitivity in alcohol abusers and iron deficiency its specificity in nonabusers. CDT can be considered a reliable marker of alcohol abuse only when iron stores are normal.

[1]  M. Mattioli,et al.  High prevalence of the His63Asp HFE mutation in italian patients with porphyria cutanea tarda , 1998, Hepatology.

[2]  P. Berthelot,et al.  A comparative study between carbohydrate-deficient transferrin and gamma-glutamyltransferase for the diagnosis of excessive drinking in a liver unit. , 1997, Journal of hepatology.

[3]  M. Grønbaek,et al.  Carbohydrate deficient transferrin (CDT) in alcoholic cirrhosis: a kinetic study. , 1997, Journal of hepatology.

[4]  R. Stauber,et al.  Carbohydrate-deficient transferrin in healthy women: relation to estrogens and iron status. , 1996, Alcoholism, clinical and experimental research.

[5]  R. Stauber,et al.  Increased carbohydrate-deficient transferrin during pregnancy: relation to sex hormones. , 1996, Alcohol and alcoholism.

[6]  M. Cappellini,et al.  Carbohydrate-deficient transferrin in alcohol and nonalcohol abusers with liver disease. , 1995, Alcoholism, clinical and experimental research.

[7]  S. R. Hillman.  Hematology in Clinical Practice , 1995 .

[8]  E. Haug,et al.  Carbohydrate-deficient transferrin and other markers of high alcohol consumption: a study of 502 patients admitted consecutively to a medical department. , 1994, Alcoholism, clinical and experimental research.

[9]  J. Poulsen,et al.  The effect of iron overload and iron reductive treatment on the serum concentration of carbohydrate‐deficient transferrin , 1994, British journal of haematology.

[10]  R. Anton,et al.  Carbohydrate-deficient transferrin and gamma-glutamyltransferase as markers of heavy alcohol consumption: gender differences. , 1994, Alcoholism, clinical and experimental research.

[11]  T. Koivula,et al.  CDT by anion-exchange chromatography followed by RIA as a marker of heavy drinking among men. , 1993, Alcoholism, clinical and experimental research.

[12]  E. Haug,et al.  Serum carbohydrate-deficient transferrin as a marker of alcohol consumption in patients with chronic liver diseases. , 1993, Alcoholism, clinical and experimental research.

[13]  M. Cappellini,et al.  Hepatitis C virus and porphyria cutanea tarda: Evidence of a strong association , 1992, Hepatology.

[14]  H. G. Eijk,et al.  Adaptation of transferrin protein and glycan synthesis. , 1992, Clinica chimica acta; international journal of clinical chemistry.

[15]  M. Tavassoli,et al.  Laboratory markers of ethanol intake and abuse: a critical appraisal. , 1992, The American journal of the medical sciences.

[16]  H Stibler,et al.  Carbohydrate-deficient transferrin in serum: a new marker of potentially harmful alcohol consumption reviewed. , 1991, Clinical chemistry.

[17]  J. Price,et al.  Desialylated transferrin and mitochondrial aspartate aminotransferase compared as laboratory markers of excessive alcohol consumption. , 1990, Clinical chemistry.

[18]  J. Jaeken,et al.  Carbohydrate deficient serum transferrin in a new systemic hereditary syndrome. , 1990, Archives of disease in childhood.

[19]  G. Beckman,et al.  Transferrin phenotype and level of carbohydrate-deficient transferrin in healthy individuals. , 1988, Alcoholism, clinical and experimental research.

[20]  M. Irving,et al.  Association between alcoholism and increased hepatic iron stores. , 1988, Alcoholism, clinical and experimental research.

[21]  S. Borg,et al.  Micro anion exchange chromatography of carbohydrate-deficient transferrin in serum in relation to alcohol consumption (Swedish Patent 8400587-5). , 1986, Alcoholism, clinical and experimental research.

[22]  E. Regoeczi,et al.  Preferential hepatic uptake of iron from rat asialotransferrin: possible engagement of two receptors. , 1986, The American journal of physiology.

[23]  R. N. Macsween,et al.  Histologic Spectrum of Alcoholic Liver Disease , 1986, Seminars in liver disease.

[24]  M. Tsutsumi,et al.  Biochemical markers of chronic alcoholism. , 1985, Alcohol.

[25]  E. Regoeczi,et al.  Transferrin glycans: a possible link between alcoholism and hepatic siderosis. , 1984, Alcoholism, clinical and experimental research.

[26]  C. Allgulander,et al.  Abnormal microheterogeneity of transferrin in serum and cerebrospinal fluid in alcoholism. , 2009, Acta medica Scandinavica.

[27]  S. Sherlock,et al.  Measurement of liver-iron concentration in needle-biopsy specimens. , 1971, Lancet.